Levin Capital Strategies’s Aura Biosciences AURA Stock Holding History

Levin Capital Strategies’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.95M	Sell	838,067 -103,333	-11%	-$739K	0.4%	67
2026 Q1	$6.3M	Sell	941,400 -94,186	-9%	-$541K	0.48%	59
2025 Q4	$5.64M	Sell	1,035,586 -591,688	-36%	-$3.51M	0.49%	49
2025 Q3	$10.1M	Buy	1,627,274 +131,714	+9%	+$861K	0.91%	36
2025 Q2	$9.36M	Buy	1,495,560 +134,792	+10%	+$788K	0.91%	40
2025 Q1	$7.97M	Buy	1,360,768 +113,149	+9%	+$856K	0.84%	45
2024 Q4	$10.3M	Buy	1,247,619 +833,984	+202%	+$7.85M	0.97%	38
2024 Q3	$3.69M	Buy	413,635 +86,169	+26%	+$739K	0.35%	59
2024 Q2	$2.48M	Buy	327,466 +216,266	+194%	+$1.58M	0.26%	59
2024 Q1	$873K	Buy	111,200 +11,200	+11%	+$92.9K	0.09%	102
2023 Q4	$886K	Buy	100,000 +18,905	+23%	+$160K	0.1%	100
2023 Q3	$727K	Buy	81,095 +11,095	+16%	+$119K	0.09%	115
2023 Q2	$865K	Buy	70,000 +55,000	+367%	+$588K	0.1%	100
2023 Q1	$139K	Buy	+15,000	New	+$156K	0.02%	207

Other funds holding AURA

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Levin Capital Strategies's AURA Position: Q2 2026 in Review

Levin Capital Strategies reduced its Aura Biosciences (AURA) stake by 11% in Q2 2026, selling an estimated $739K and leaving 838,067 shares worth $5.95M. The position accounts for 0.4% of the portfolio, ranked #67.

Levin Capital Strategies first reported a position in AURA in Q1 2023 and has held it in 14 quarters since. The position peaked at $10.3M in Q4 2024. 20 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

Levin Capital Strategies held 838,067 shares of Aura Biosciences worth $5.95M as of Q2 2026.
Levin Capital Strategies sold 103,333 Aura Biosciences shares in Q2 2026, an estimated $739K.
Aura Biosciences made up 0.4% of Levin Capital Strategies's portfolio in Q2 2026, its #67 holding.
Levin Capital Strategies first reported a position in Aura Biosciences in Q1 2023 and has held it in 14 quarters since.
Levin Capital Strategies's Aura Biosciences position peaked at $10.3M in Q4 2024.
20 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Levin Capital Strategies's 13F filing for Q2 2026, filed 31 Jul 2026.